![](/class/preview.php?img=images/image_1067.jpg&w=329&h=193)
![](/templates/custom_aifp_fmd/img/ico-date.png)
Letter to stakeholders regarding the implementation of safety features
European Commission together with European Medicines Agency and HMA announce an important message to all stakeholders regarding the implementation of…
Read more![](/templates/custom_aifp_fmd/img/ico-link.png)
European Commission together with European Medicines Agency and HMA announce an important message to all stakeholders regarding the implementation of…
Read moreThe Government approved an amendment to the Act on Pharmaceuticals (No. 378/2007 Coll.), which aims to enable the functioning of the anti-counterfeiting…
Read moreBased on the NOOL Board’s proposal a reduction of the User fee for 2019 for MAHs with very small or zero revenues was approved by General Meeting…
Read moreIn January 2018, EMVO announced that the very last opportunity to on-board timely is June 2018. Any on- boarding after that date may entail a risk to…
Read more